Li Hong, the general manager, believes that innovation is the core competitiveness of enterprises. She believes that without innovation, an enterprise cannot be bigger and stronger. She innovated the process of erythromycin enteric-coated pellets capsules and achieved success. Its technological innovation ranks first in the country. This variety was listed in the Pharmacopoeia of China, and was rated as "Chongqing Key New Product", achieving an additional output value of more than 50 million yuan and a profit and tax of more than 0/0 million yuan. Shen Yan Jianwei Capsule, developed for the treatment of atrophic gastritis, is a pure Chinese medicine preparation with independent intellectual property rights. In order to treat women's climacteric syndrome, a patented new drug "Dizhen Granule" was developed. He presided over the research on "Xifeng Zhijing Capsule", which is the first pure Chinese medicine preparation for treating Parkinson's disease in the world and was listed as "Chongqing Key Scientific and Technological Key Project in 2008".